nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC5—Cisplatin—bone cancer	0.331	0.655	CbGbCtD
Dipyridamole—ABCC4—Methotrexate—bone cancer	0.103	0.204	CbGbCtD
Dipyridamole—ABCB1—Cisplatin—bone cancer	0.0309	0.061	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—bone cancer	0.0207	0.0409	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—bone cancer	0.02	0.0396	CbGbCtD
Dipyridamole—PDE8B—leg—bone cancer	0.0124	0.127	CbGeAlD
Dipyridamole—PDE8B—forelimb—bone cancer	0.0123	0.126	CbGeAlD
Dipyridamole—PDE8B—hindlimb—bone cancer	0.0111	0.113	CbGeAlD
Dipyridamole—PDE8B—appendage—bone cancer	0.00952	0.0973	CbGeAlD
Dipyridamole—PDE6B—connective tissue—bone cancer	0.00471	0.0482	CbGeAlD
Dipyridamole—PRUNE—tendon—bone cancer	0.00341	0.0348	CbGeAlD
Dipyridamole—PDE6D—bone marrow—bone cancer	0.00319	0.0326	CbGeAlD
Dipyridamole—PDE6B—spinal cord—bone cancer	0.00312	0.0319	CbGeAlD
Dipyridamole—PDE11A—tendon—bone cancer	0.00301	0.0308	CbGeAlD
Dipyridamole—PDE3B—connective tissue—bone cancer	0.00265	0.0271	CbGeAlD
Dipyridamole—PDE7B—tendon—bone cancer	0.00235	0.024	CbGeAlD
Dipyridamole—ADA—connective tissue—bone cancer	0.00201	0.0206	CbGeAlD
Dipyridamole—PDE10A—tendon—bone cancer	0.00196	0.02	CbGeAlD
Dipyridamole—PDE2A—tendon—bone cancer	0.00196	0.02	CbGeAlD
Dipyridamole—PDE2A—spinal cord—bone cancer	0.00189	0.0193	CbGeAlD
Dipyridamole—PDE3B—bone marrow—bone cancer	0.00177	0.0181	CbGeAlD
Dipyridamole—PDE8A—tendon—bone cancer	0.00168	0.0172	CbGeAlD
Dipyridamole—PDE5A—connective tissue—bone cancer	0.00167	0.017	CbGeAlD
Dipyridamole—PDE1A—tendon—bone cancer	0.00163	0.0166	CbGeAlD
Dipyridamole—PDE8A—spinal cord—bone cancer	0.00162	0.0166	CbGeAlD
Dipyridamole—PDE1A—spinal cord—bone cancer	0.00157	0.016	CbGeAlD
Dipyridamole—SLC29A1—connective tissue—bone cancer	0.0014	0.0143	CbGeAlD
Dipyridamole—ADA—tendon—bone cancer	0.00138	0.0141	CbGeAlD
Dipyridamole—ADA—bone marrow—bone cancer	0.00134	0.0137	CbGeAlD
Dipyridamole—PDE5A—tendon—bone cancer	0.00115	0.0117	CbGeAlD
Dipyridamole—PDE3A—tendon—bone cancer	0.00111	0.0114	CbGeAlD
Dipyridamole—ABCC5—tendon—bone cancer	0.00105	0.0107	CbGeAlD
Dipyridamole—ABCC5—bone marrow—bone cancer	0.00101	0.0104	CbGeAlD
Dipyridamole—SLC29A1—tendon—bone cancer	0.000962	0.00983	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—bone cancer	0.000932	0.00953	CbGeAlD
Dipyridamole—ABCC4—tendon—bone cancer	0.000726	0.00742	CbGeAlD
Dipyridamole—ABCC4—bone marrow—bone cancer	0.000703	0.00719	CbGeAlD
Dipyridamole—Tremor—Cisplatin—bone cancer	0.000683	0.00355	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Methotrexate—bone cancer	0.000678	0.00352	CcSEcCtD
Dipyridamole—Ill-defined disorder—Cisplatin—bone cancer	0.000676	0.00351	CcSEcCtD
Dipyridamole—Anaemia—Cisplatin—bone cancer	0.000674	0.0035	CcSEcCtD
Dipyridamole—Hot flush—Epirubicin—bone cancer	0.000664	0.00345	CcSEcCtD
Dipyridamole—Increased appetite—Epirubicin—bone cancer	0.000661	0.00343	CcSEcCtD
Dipyridamole—Menopausal symptoms—Epirubicin—bone cancer	0.000659	0.00342	CcSEcCtD
Dipyridamole—Hepatic function abnormal—Doxorubicin—bone cancer	0.000658	0.00342	CcSEcCtD
Dipyridamole—Malaise—Cisplatin—bone cancer	0.000657	0.00341	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Epirubicin—bone cancer	0.000642	0.00333	CcSEcCtD
Dipyridamole—Eye pain—Doxorubicin—bone cancer	0.000637	0.00331	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Epirubicin—bone cancer	0.000634	0.00329	CcSEcCtD
Dipyridamole—Convulsion—Cisplatin—bone cancer	0.000631	0.00328	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000621	0.00323	CcSEcCtD
Dipyridamole—Myalgia—Cisplatin—bone cancer	0.00062	0.00322	CcSEcCtD
Dipyridamole—Anxiety—Cisplatin—bone cancer	0.000618	0.00321	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000616	0.0032	CcSEcCtD
Dipyridamole—Hot flush—Doxorubicin—bone cancer	0.000615	0.00319	CcSEcCtD
Dipyridamole—Discomfort—Cisplatin—bone cancer	0.000613	0.00318	CcSEcCtD
Dipyridamole—Increased appetite—Doxorubicin—bone cancer	0.000612	0.00318	CcSEcCtD
Dipyridamole—Migraine—Epirubicin—bone cancer	0.000612	0.00318	CcSEcCtD
Dipyridamole—Menopausal symptoms—Doxorubicin—bone cancer	0.000609	0.00316	CcSEcCtD
Dipyridamole—Oedema—Cisplatin—bone cancer	0.000595	0.00309	CcSEcCtD
Dipyridamole—Anaphylactic shock—Cisplatin—bone cancer	0.000595	0.00309	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000594	0.00308	CcSEcCtD
Dipyridamole—Cardiac arrest—Epirubicin—bone cancer	0.000591	0.00307	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Doxorubicin—bone cancer	0.000587	0.00305	CcSEcCtD
Dipyridamole—Nervous system disorder—Cisplatin—bone cancer	0.000583	0.00303	CcSEcCtD
Dipyridamole—Thrombocytopenia—Cisplatin—bone cancer	0.000582	0.00302	CcSEcCtD
Dipyridamole—Tachycardia—Cisplatin—bone cancer	0.00058	0.00301	CcSEcCtD
Dipyridamole—Skin disorder—Cisplatin—bone cancer	0.000578	0.003	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000575	0.00299	CcSEcCtD
Dipyridamole—Hyperhidrosis—Cisplatin—bone cancer	0.000575	0.00299	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Epirubicin—bone cancer	0.000568	0.00295	CcSEcCtD
Dipyridamole—Abdominal pain upper—Epirubicin—bone cancer	0.000568	0.00295	CcSEcCtD
Dipyridamole—Migraine—Doxorubicin—bone cancer	0.000566	0.00294	CcSEcCtD
Dipyridamole—Hypotension—Cisplatin—bone cancer	0.000556	0.00289	CcSEcCtD
Dipyridamole—Abdominal discomfort—Methotrexate—bone cancer	0.00055	0.00286	CcSEcCtD
Dipyridamole—Cardiac arrest—Doxorubicin—bone cancer	0.000547	0.00284	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000542	0.00281	CcSEcCtD
Dipyridamole—Dysphagia—Epirubicin—bone cancer	0.000537	0.00279	CcSEcCtD
Dipyridamole—Paraesthesia—Cisplatin—bone cancer	0.000534	0.00277	CcSEcCtD
Dipyridamole—Dyspnoea—Cisplatin—bone cancer	0.00053	0.00275	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—bone cancer	0.000525	0.00273	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—bone cancer	0.000525	0.00273	CcSEcCtD
Dipyridamole—Angina pectoris—Epirubicin—bone cancer	0.000523	0.00272	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Cisplatin—bone cancer	0.000513	0.00267	CcSEcCtD
Dipyridamole—Pain—Cisplatin—bone cancer	0.000509	0.00264	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—bone cancer	0.000497	0.00258	CcSEcCtD
Dipyridamole—Feeling abnormal—Cisplatin—bone cancer	0.00049	0.00255	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—bone cancer	0.000484	0.00251	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—bone cancer	0.000462	0.0024	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—bone cancer	0.000459	0.00239	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—bone cancer	0.000459	0.00239	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—bone cancer	0.000456	0.00237	CcSEcCtD
Dipyridamole—Hypersensitivity—Cisplatin—bone cancer	0.000438	0.00228	CcSEcCtD
Dipyridamole—Bradycardia—Epirubicin—bone cancer	0.000438	0.00227	CcSEcCtD
Dipyridamole—Haemoglobin—Epirubicin—bone cancer	0.000432	0.00224	CcSEcCtD
Dipyridamole—Rhinitis—Epirubicin—bone cancer	0.000431	0.00224	CcSEcCtD
Dipyridamole—Haemorrhage—Epirubicin—bone cancer	0.00043	0.00223	CcSEcCtD
Dipyridamole—Hepatitis—Epirubicin—bone cancer	0.00043	0.00223	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—bone cancer	0.000428	0.00222	CcSEcCtD
Dipyridamole—Hypoaesthesia—Epirubicin—bone cancer	0.000428	0.00222	CcSEcCtD
Dipyridamole—Asthenia—Cisplatin—bone cancer	0.000427	0.00222	CcSEcCtD
Dipyridamole—Pharyngitis—Epirubicin—bone cancer	0.000427	0.00222	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—bone cancer	0.000426	0.00221	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—bone cancer	0.000417	0.00216	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—bone cancer	0.000415	0.00215	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—bone cancer	0.000414	0.00215	CcSEcCtD
Dipyridamole—Chills—Methotrexate—bone cancer	0.000412	0.00214	CcSEcCtD
Dipyridamole—Diarrhoea—Cisplatin—bone cancer	0.000407	0.00211	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—bone cancer	0.000406	0.00211	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—bone cancer	0.000405	0.0021	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—bone cancer	0.000401	0.00208	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—bone cancer	0.0004	0.00208	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—bone cancer	0.000399	0.00207	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—bone cancer	0.000399	0.00207	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—bone cancer	0.000399	0.00207	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—bone cancer	0.000398	0.00207	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—bone cancer	0.000398	0.00207	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—bone cancer	0.000396	0.00206	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—bone cancer	0.000395	0.00205	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—bone cancer	0.000392	0.00203	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—bone cancer	0.00039	0.00203	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—bone cancer	0.000388	0.00202	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—bone cancer	0.000387	0.00201	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—bone cancer	0.000387	0.00201	CcSEcCtD
Dipyridamole—Chills—Epirubicin—bone cancer	0.000386	0.002	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—bone cancer	0.000384	0.00199	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—bone cancer	0.00038	0.00197	CcSEcCtD
Dipyridamole—Vomiting—Cisplatin—bone cancer	0.000378	0.00196	CcSEcCtD
Dipyridamole—Rash—Cisplatin—bone cancer	0.000375	0.00195	CcSEcCtD
Dipyridamole—Dermatitis—Cisplatin—bone cancer	0.000375	0.00195	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—bone cancer	0.000371	0.00193	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—bone cancer	0.000371	0.00193	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—bone cancer	0.00037	0.00192	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—bone cancer	0.000369	0.00192	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—bone cancer	0.000369	0.00192	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—bone cancer	0.000369	0.00191	CcSEcCtD
Dipyridamole—Tension—Epirubicin—bone cancer	0.000367	0.00191	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—bone cancer	0.000366	0.0019	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—bone cancer	0.000363	0.00189	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—bone cancer	0.000362	0.00188	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—bone cancer	0.000361	0.00187	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—bone cancer	0.000361	0.00187	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—bone cancer	0.00036	0.00187	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—bone cancer	0.000359	0.00187	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—bone cancer	0.000359	0.00187	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—bone cancer	0.000358	0.00186	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—bone cancer	0.000357	0.00185	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—bone cancer	0.000355	0.00185	CcSEcCtD
Dipyridamole—Nausea—Cisplatin—bone cancer	0.000353	0.00183	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—bone cancer	0.000352	0.00183	CcSEcCtD
Dipyridamole—Cough—Methotrexate—bone cancer	0.000349	0.00181	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—bone cancer	0.000347	0.0018	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—bone cancer	0.000346	0.0018	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—bone cancer	0.000346	0.0018	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—bone cancer	0.000341	0.00177	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—bone cancer	0.00034	0.00177	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—bone cancer	0.00034	0.00177	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—bone cancer	0.00034	0.00177	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—bone cancer	0.00034	0.00176	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—bone cancer	0.000339	0.00176	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000338	0.00176	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—bone cancer	0.000337	0.00175	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—bone cancer	0.000336	0.00175	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—bone cancer	0.000336	0.00175	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—bone cancer	0.000336	0.00175	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—bone cancer	0.000336	0.00174	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—bone cancer	0.000335	0.00174	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—bone cancer	0.000333	0.00173	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—bone cancer	0.000331	0.00172	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—bone cancer	0.000329	0.00171	CcSEcCtD
Dipyridamole—Cough—Epirubicin—bone cancer	0.000327	0.0017	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—bone cancer	0.000326	0.00169	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—bone cancer	0.000324	0.00168	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—bone cancer	0.000323	0.00168	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—bone cancer	0.000321	0.00167	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—bone cancer	0.00032	0.00166	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—bone cancer	0.00032	0.00166	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—bone cancer	0.00032	0.00166	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—bone cancer	0.000319	0.00165	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—bone cancer	0.000319	0.00165	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—bone cancer	0.000319	0.00165	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—bone cancer	0.000318	0.00165	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—bone cancer	0.000317	0.00165	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000316	0.00164	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—bone cancer	0.000316	0.00164	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—bone cancer	0.000315	0.00163	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—bone cancer	0.000312	0.00162	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—bone cancer	0.000312	0.00162	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—bone cancer	0.000311	0.00162	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—bone cancer	0.000311	0.00161	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—bone cancer	0.000306	0.00159	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—bone cancer	0.000305	0.00159	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—bone cancer	0.000305	0.00159	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—bone cancer	0.000305	0.00158	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—bone cancer	0.000304	0.00158	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—bone cancer	0.000302	0.00157	CcSEcCtD
Dipyridamole—Shock—Epirubicin—bone cancer	0.0003	0.00156	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—bone cancer	0.0003	0.00156	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—bone cancer	0.0003	0.00156	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—bone cancer	0.000299	0.00155	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—bone cancer	0.000299	0.00155	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—bone cancer	0.000298	0.00155	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000297	0.00154	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—bone cancer	0.000297	0.00154	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—bone cancer	0.000294	0.00153	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—bone cancer	0.000293	0.00152	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000293	0.00152	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—bone cancer	0.000291	0.00151	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—bone cancer	0.000291	0.00151	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—bone cancer	0.00029	0.00151	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—bone cancer	0.000288	0.0015	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—bone cancer	0.000287	0.00149	CcSEcCtD
Dipyridamole—Hypotension—Epirubicin—bone cancer	0.000285	0.00148	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—bone cancer	0.000283	0.00147	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—bone cancer	0.000283	0.00147	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000282	0.00146	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—bone cancer	0.000281	0.00146	CcSEcCtD
Dipyridamole—Pain—Methotrexate—bone cancer	0.000279	0.00145	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000278	0.00144	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—bone cancer	0.000278	0.00144	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—bone cancer	0.000277	0.00144	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—bone cancer	0.000277	0.00144	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—bone cancer	0.000276	0.00143	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—bone cancer	0.000275	0.00143	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—bone cancer	0.000274	0.00142	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—bone cancer	0.000273	0.00142	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—bone cancer	0.000272	0.00141	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—bone cancer	0.000272	0.00141	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—bone cancer	0.000269	0.0014	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—bone cancer	0.000269	0.0014	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—bone cancer	0.000267	0.00139	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—bone cancer	0.000264	0.00137	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000264	0.00137	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—bone cancer	0.000263	0.00137	CcSEcCtD
Dipyridamole—Pain—Epirubicin—bone cancer	0.000261	0.00136	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—bone cancer	0.000259	0.00135	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—bone cancer	0.000258	0.00134	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000257	0.00134	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—bone cancer	0.000254	0.00132	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—bone cancer	0.000252	0.00131	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—bone cancer	0.000252	0.00131	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—bone cancer	0.000251	0.0013	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—bone cancer	0.00025	0.0013	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—bone cancer	0.000249	0.00129	CcSEcCtD
Dipyridamole—ABCB1—bone marrow—bone cancer	0.000245	0.0025	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000244	0.00127	CcSEcCtD
Dipyridamole—ABCB1—spinal cord—bone cancer	0.000244	0.00249	CbGeAlD
Dipyridamole—Fatigue—Doxorubicin—bone cancer	0.000244	0.00127	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—bone cancer	0.000243	0.00126	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—bone cancer	0.000242	0.00125	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—bone cancer	0.000241	0.00125	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—bone cancer	0.00024	0.00125	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—bone cancer	0.000234	0.00122	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—bone cancer	0.000233	0.00121	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000231	0.0012	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—bone cancer	0.000231	0.0012	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—bone cancer	0.000225	0.00117	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—bone cancer	0.000225	0.00117	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—bone cancer	0.000223	0.00116	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—bone cancer	0.000223	0.00116	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—bone cancer	0.000219	0.00114	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—bone cancer	0.000216	0.00112	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—bone cancer	0.000216	0.00112	CcSEcCtD
Dipyridamole—Diarrhoea—Epirubicin—bone cancer	0.000209	0.00109	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—bone cancer	0.000208	0.00108	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—bone cancer	0.000208	0.00108	CcSEcCtD
Dipyridamole—Rash—Methotrexate—bone cancer	0.000206	0.00107	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—bone cancer	0.000206	0.00107	CcSEcCtD
Dipyridamole—Headache—Methotrexate—bone cancer	0.000204	0.00106	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—bone cancer	0.000203	0.00105	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—bone cancer	0.000202	0.00105	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—bone cancer	0.0002	0.00104	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—bone cancer	0.000194	0.00101	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—bone cancer	0.000194	0.00101	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—bone cancer	0.000193	0.001	CcSEcCtD
Dipyridamole—Rash—Epirubicin—bone cancer	0.000193	0.001	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—bone cancer	0.000192	0.000999	CcSEcCtD
Dipyridamole—Headache—Epirubicin—bone cancer	0.000191	0.000994	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—bone cancer	0.000187	0.00097	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—bone cancer	0.000181	0.000942	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—bone cancer	0.00018	0.000933	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—bone cancer	0.000178	0.000925	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—bone cancer	0.000178	0.000924	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—bone cancer	0.000177	0.000919	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—bone cancer	0.000168	0.000872	CcSEcCtD
Dipyridamole—PDE6G—Signaling Pathways—TGFBR2—bone cancer	0.000105	0.000516	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—BRAF—bone cancer	0.000104	0.000513	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—BRAF—bone cancer	0.000104	0.000513	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—TP53—bone cancer	0.000104	0.000513	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—EGFR—bone cancer	0.000104	0.00051	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GRM1—bone cancer	0.000104	0.00051	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—KIT—bone cancer	0.000104	0.000509	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—KIT—bone cancer	0.000103	0.000505	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL3—bone cancer	0.000103	0.000504	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL3—bone cancer	0.000103	0.000504	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFBR2—bone cancer	0.000102	0.000503	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—KIT—bone cancer	0.000102	0.000502	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—DHFR—bone cancer	0.000102	0.000502	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ENO2—bone cancer	0.000101	0.000495	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IGF1R—bone cancer	0.0001	0.000492	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IGF1R—bone cancer	9.88e-05	0.000485	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	9.79e-05	0.000481	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.77e-05	0.00048	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—BRAF—bone cancer	9.75e-05	0.000479	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—EGFR—bone cancer	9.69e-05	0.000476	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IGF1R—bone cancer	9.62e-05	0.000473	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—BRAF—bone cancer	9.61e-05	0.000472	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ATF1—bone cancer	9.61e-05	0.000472	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—KIT—bone cancer	9.45e-05	0.000464	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—KIT—bone cancer	9.45e-05	0.000464	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—KIT—bone cancer	9.39e-05	0.000462	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL3—bone cancer	9.38e-05	0.000461	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—DHFR—bone cancer	9.35e-05	0.00046	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SMO—bone cancer	9.33e-05	0.000459	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—GSTP1—bone cancer	9.33e-05	0.000458	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—bone cancer	9.3e-05	0.000457	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—bone cancer	9.3e-05	0.000457	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—KIT—bone cancer	9.21e-05	0.000452	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PLAU—bone cancer	8.89e-05	0.000437	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—BRAF—bone cancer	8.88e-05	0.000436	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—BRAF—bone cancer	8.88e-05	0.000436	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—EGFR—bone cancer	8.86e-05	0.000435	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—MDM2—bone cancer	8.84e-05	0.000434	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MDM2—bone cancer	8.75e-05	0.00043	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MDM2—bone cancer	8.75e-05	0.00043	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GNA11—bone cancer	8.74e-05	0.00043	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SMO—bone cancer	8.74e-05	0.000429	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—BRAF—bone cancer	8.66e-05	0.000425	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—EGFR—bone cancer	8.61e-05	0.000423	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—EGFR—bone cancer	8.61e-05	0.000423	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—EGFR—bone cancer	8.54e-05	0.00042	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—EGFR—bone cancer	8.54e-05	0.00042	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—GNA11—bone cancer	8.54e-05	0.000419	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SMO—bone cancer	8.5e-05	0.000418	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.43e-05	0.000414	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KIT—bone cancer	8.42e-05	0.000414	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—EGFR—bone cancer	8.39e-05	0.000412	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MDM2—bone cancer	8.17e-05	0.000401	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFBR2—bone cancer	8.09e-05	0.000398	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFBR2—bone cancer	8.09e-05	0.000398	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—MDM2—bone cancer	8.09e-05	0.000397	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MDM2—bone cancer	8.06e-05	0.000396	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SMO—bone cancer	7.99e-05	0.000393	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—GNA11—bone cancer	7.99e-05	0.000393	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ATF1—bone cancer	7.94e-05	0.00039	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CYP3A4—bone cancer	7.93e-05	0.000389	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—BRAF—bone cancer	7.92e-05	0.000389	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PTGS2—bone cancer	7.87e-05	0.000387	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KIT—bone cancer	7.83e-05	0.000385	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KIT—bone cancer	7.83e-05	0.000385	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—GNA11—bone cancer	7.78e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PTGS2—bone cancer	7.77e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL3—bone cancer	7.74e-05	0.00038	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—JUN—bone cancer	7.69e-05	0.000378	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—EGFR—bone cancer	7.67e-05	0.000377	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NDUFA12—bone cancer	7.63e-05	0.000375	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—JUN—bone cancer	7.61e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—JUN—bone cancer	7.61e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MDM2—bone cancer	7.44e-05	0.000366	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MDM2—bone cancer	7.44e-05	0.000366	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ATF1—bone cancer	7.43e-05	0.000365	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFBR2—bone cancer	7.4e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MMP9—bone cancer	7.4e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MMP9—bone cancer	7.4e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—MDM2—bone cancer	7.4e-05	0.000363	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—BRAF—bone cancer	7.36e-05	0.000362	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—BRAF—bone cancer	7.36e-05	0.000362	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—GNA11—bone cancer	7.31e-05	0.000359	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SMO—bone cancer	7.31e-05	0.000359	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.26e-05	0.000357	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KIT—bone cancer	7.26e-05	0.000357	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MDM2—bone cancer	7.25e-05	0.000356	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL3—bone cancer	7.25e-05	0.000356	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ATF1—bone cancer	7.23e-05	0.000355	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KIT—bone cancer	7.16e-05	0.000352	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—EGFR—bone cancer	7.13e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—EGFR—bone cancer	7.13e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL3—bone cancer	7.05e-05	0.000346	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—JUN—bone cancer	7.03e-05	0.000345	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KIT—bone cancer	6.98e-05	0.000343	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—BRAF—bone cancer	6.82e-05	0.000335	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ATF1—bone cancer	6.8e-05	0.000334	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GSTP1—bone cancer	6.78e-05	0.000333	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—BRAF—bone cancer	6.73e-05	0.000331	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GNA11—bone cancer	6.69e-05	0.000328	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MDM2—bone cancer	6.63e-05	0.000326	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL3—bone cancer	6.63e-05	0.000326	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFBR2—bone cancer	6.62e-05	0.000325	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—EGFR—bone cancer	6.61e-05	0.000325	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—BRAF—bone cancer	6.56e-05	0.000322	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—JUN—bone cancer	6.47e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—JUN—bone cancer	6.47e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—JUN—bone cancer	6.43e-05	0.000316	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—EGFR—bone cancer	6.36e-05	0.000312	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NT5C3A—bone cancer	6.33e-05	0.000311	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—JUN—bone cancer	6.3e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MMP9—bone cancer	6.29e-05	0.000309	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MMP9—bone cancer	6.29e-05	0.000309	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1R—bone cancer	6.23e-05	0.000306	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ATF1—bone cancer	6.22e-05	0.000305	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFBR2—bone cancer	6.2e-05	0.000304	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MDM2—bone cancer	6.17e-05	0.000303	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MDM2—bone cancer	6.17e-05	0.000303	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MMP9—bone cancer	6.13e-05	0.000301	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL3—bone cancer	6.06e-05	0.000298	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—bone cancer	6.04e-05	0.000297	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFBR2—bone cancer	6.03e-05	0.000296	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—bone cancer	6.02e-05	0.000296	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KIT—bone cancer	5.98e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—bone cancer	5.98e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—bone cancer	5.98e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1R—bone cancer	5.83e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—JUN—bone cancer	5.77e-05	0.000283	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MDM2—bone cancer	5.72e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1R—bone cancer	5.67e-05	0.000279	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFBR2—bone cancer	5.67e-05	0.000278	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MDM2—bone cancer	5.64e-05	0.000277	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—bone cancer	5.61e-05	0.000276	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—bone cancer	5.58e-05	0.000274	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—bone cancer	5.53e-05	0.000272	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KIT—bone cancer	5.52e-05	0.000271	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KIT—bone cancer	5.52e-05	0.000271	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—bone cancer	5.5e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MDM2—bone cancer	5.5e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—bone cancer	5.48e-05	0.000269	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KIT—bone cancer	5.47e-05	0.000269	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.38e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—JUN—bone cancer	5.36e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—JUN—bone cancer	5.36e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1R—bone cancer	5.33e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—bone cancer	5.22e-05	0.000256	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—bone cancer	5.22e-05	0.000256	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—BRAF—bone cancer	5.19e-05	0.000255	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—BRAF—bone cancer	5.19e-05	0.000255	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.19e-05	0.000255	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFBR2—bone cancer	5.18e-05	0.000255	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—bone cancer	5.16e-05	0.000253	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—bone cancer	5.09e-05	0.00025	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—bone cancer	5.09e-05	0.00025	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—bone cancer	5.06e-05	0.000248	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KIT—bone cancer	5.05e-05	0.000248	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—bone cancer	5.02e-05	0.000247	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—bone cancer	5.02e-05	0.000247	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—JUN—bone cancer	4.97e-05	0.000244	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—bone cancer	4.96e-05	0.000244	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—JUN—bone cancer	4.9e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1R—bone cancer	4.88e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—bone cancer	4.84e-05	0.000238	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—bone cancer	4.83e-05	0.000237	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—JUN—bone cancer	4.78e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—bone cancer	4.77e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—BRAF—bone cancer	4.75e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—bone cancer	4.72e-05	0.000232	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MDM2—bone cancer	4.71e-05	0.000231	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.68e-05	0.00023	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—bone cancer	4.65e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—bone cancer	4.53e-05	0.000223	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KIT—bone cancer	4.52e-05	0.000222	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MDM2—bone cancer	4.35e-05	0.000214	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MDM2—bone cancer	4.35e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MDM2—bone cancer	4.31e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—bone cancer	4.27e-05	0.00021	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—bone cancer	4.27e-05	0.00021	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—BRAF—bone cancer	4.25e-05	0.000209	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KIT—bone cancer	4.23e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—bone cancer	4.21e-05	0.000207	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—bone cancer	4.21e-05	0.000207	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—bone cancer	4.19e-05	0.000206	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—bone cancer	4.19e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—bone cancer	4.16e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—bone cancer	4.12e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KIT—bone cancer	4.11e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—JUN—bone cancer	4.1e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MDM2—bone cancer	3.98e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—BRAF—bone cancer	3.97e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—bone cancer	3.91e-05	0.000192	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KIT—bone cancer	3.87e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—BRAF—bone cancer	3.87e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—bone cancer	3.85e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—bone cancer	3.85e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—bone cancer	3.84e-05	0.000188	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—bone cancer	3.81e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—bone cancer	3.76e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—bone cancer	3.75e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—JUN—bone cancer	3.75e-05	0.000184	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.68e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—BRAF—bone cancer	3.64e-05	0.000179	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—bone cancer	3.57e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MDM2—bone cancer	3.56e-05	0.000175	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—bone cancer	3.54e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—bone cancer	3.54e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KIT—bone cancer	3.54e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—bone cancer	3.52e-05	0.000173	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—bone cancer	3.51e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MDM2—bone cancer	3.33e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BRAF—bone cancer	3.33e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—bone cancer	3.28e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MDM2—bone cancer	3.24e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—bone cancer	3.24e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—bone cancer	3.22e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—bone cancer	3.22e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—bone cancer	3.15e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—bone cancer	3.09e-05	0.000152	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.09e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—bone cancer	3.05e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—bone cancer	3.01e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—bone cancer	2.97e-05	0.000146	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—bone cancer	2.97e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—bone cancer	2.94e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—bone cancer	2.89e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—bone cancer	2.82e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—bone cancer	2.82e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—bone cancer	2.79e-05	0.000137	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO2—bone cancer	2.77e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—bone cancer	2.74e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—bone cancer	2.72e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—bone cancer	2.65e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—bone cancer	2.58e-05	0.000127	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DHFR—bone cancer	2.57e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—bone cancer	2.43e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—bone cancer	2.42e-05	0.000119	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNA11—bone cancer	2.4e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—bone cancer	2.36e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—bone cancer	2.28e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—bone cancer	2.21e-05	0.000109	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP3A4—bone cancer	2.18e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—bone cancer	2.08e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—bone cancer	2.04e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—bone cancer	1.91e-05	9.39e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—bone cancer	1.9e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—bone cancer	1.86e-05	9.15e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—bone cancer	1.86e-05	9.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—bone cancer	1.75e-05	8.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—bone cancer	1.6e-05	7.85e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—bone cancer	9.65e-06	4.74e-05	CbGpPWpGaD
